Literature DB >> 12219157

Cost of malaria control in China: Henan's consolidation programme from community and government perspectives.

Sukhan Jackson1, Adrian C Sleigh, Xi-Li Liu.   

Abstract

OBJECTIVE: To assist with strategic planning for the eradication of malaria in Henan Province, China, which reached the consolidation phase of malaria control in 1992, when only 318 malaria cases were reported.
METHODS: We conducted a prospective two-year study of the costs for Henan's malaria control programme. We used a cost model that could also be applied to other malaria programmes in mainland China, and analysed the cost of the three components of Henan's malaria programme: suspected malaria case management, vector surveillance, and population blood surveys. Primary cost data were collected from the government, and data on suspected malaria patients were collected in two malaria counties (population 2 093 100). We enlisted the help of 260 village doctors in six townships or former communes (population 247 762), and studied all 12 325 reported cases of suspected malaria in their catchment areas in 1994 and 1995.
FINDINGS: The average annual government investment in malaria control was estimated to be US$ 111 516 (case-management 59%; active blood surveys 25%; vector surveillance 12%; and contingencies and special projects 4%). The average cost (direct and indirect) for patients seeking treatment for suspected malaria was US$ 3.48, equivalent to 10 days' income for rural residents. Each suspected malaria case cost the government an average of US$ 0.78.
CONCLUSION: Further cuts in government funding will increase future costs when epidemic malaria returns; investment in malaria control should therefore continue at least at current levels of US$ 0.03 per person at risk.

Entities:  

Mesh:

Year:  2002        PMID: 12219157      PMCID: PMC2567576     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

Review 1.  Costs and financial feasibility of malaria elimination.

Authors:  Oliver Sabot; Justin M Cohen; Michelle S Hsiang; James G Kahn; Suprotik Basu; Linhua Tang; Bin Zheng; Qi Gao; Linda Zou; Allison Tatarsky; Shahina Aboobakar; Jennifer Usas; Scott Barrett; Jessica L Cohen; Dean T Jamison; Richard G A Feachem
Journal:  Lancet       Date:  2010-10-28       Impact factor: 79.321

2.  Nanotechnology for the poor?

Authors:  Guillermo Foladori; Noela Invernizzi
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.069

3.  The economic burden of malaria: a systematic review.

Authors:  Mônica V Andrade; Kenya Noronha; Bernardo P C Diniz; Gilvan Guedes; Lucas R Carvalho; Valéria A Silva; Júlia A Calazans; André S Santos; Daniel N Silva; Marcia C Castro
Journal:  Malar J       Date:  2022-10-05       Impact factor: 3.469

4.  Border malaria in China: knowledge and use of personal protection by minority populations and implications for malaria control: a questionnaire-based survey.

Authors:  Sarah J Moore; Xia Min; Nigel Hill; Caroline Jones; Zhang Zaixing; Mary M Cameron
Journal:  BMC Public Health       Date:  2008-10-01       Impact factor: 3.295

Review 5.  Malaria eradication: the economic, financial and institutional challenge.

Authors:  Anne Mills; Yoel Lubell; Kara Hanson
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

6.  The economic burden of malaria on the household in south-central Vietnam.

Authors:  Chantal M Morel; Ngo Duc Thang; Nguyen Xuan Xa; Le Xuan Hung; Le Khan Thuan; Pham Van Ky; Annette Erhart; Anne J Mills; Umberto D'Alessandro
Journal:  Malar J       Date:  2008-08-27       Impact factor: 2.979

7.  Economic cost analysis of malaria case management at the household level during the malaria elimination phase in The People's Republic of China.

Authors:  Shang Xia; Jin-Xiang Ma; Duo-Quan Wang; Shi-Zhu Li; David Rollinson; Shui-Sen Zhou; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2016-06-03       Impact factor: 4.520

Review 8.  The economics of malaria control and elimination: a systematic review.

Authors:  Rima Shretta; Anton L V Avanceña; Arian Hatefi
Journal:  Malar J       Date:  2016-12-12       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.